AstraZeneca plc vs Equinix Inc — how do they compare? AstraZeneca plc trades at $158.1 (market cap $248.14B), while Equinix Inc trades at $1,032.41 (market cap $101.87B). The key difference: AstraZeneca plc is far larger — about 2.4× Equinix Inc's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | EQIX | |
|---|---|---|
Market Cap | $248.14B | $101.87B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $1.12K |
52-Week Low | $147.06 | $726.09 |
Enterprise Value | $275.41B | $123.00B |
Dividend Yield | 2.01% | 2% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →